|
|
Zovirax
Treatment of patients with ankylosing spondylitis 303 06 ; . Active and progressive psoriatic arthritis 304 06 ; Rheumatoid arthritis 305 06 ; Treatment of persistent asthma in adults and children over 6 years of age.
1. Dressman JB, Amidone GL, Reppas C, Shah VP. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res. 1998; 15: 11Y22. New drugs added since June 2002 indicated in bold. ANTIRETROVIRALS NRTIs- abacavir Ziagen ; , abacavir lamivudine zidovudine Trizivir ; , didanosine ddI, Videx , Videx EC ; , lamivudine Epivir, 3TC ; , lamivudine zidovudine Combivir ; , stavudine d4T, Zerit ; , tenofovir Viread ; , zalcitabine ddC, HIVID ; , zidovudine AZT, Retrovir ; . PIs- amprenavir Agenerase ; , indinavir Crixivan ; , lopinavir ritonavir Kaletra ; , nelfinavir Viracept ; , ritonavir Norvir ; , saquinavir Fortovase, Invirase ; . nNRTIs- delavirdine Rescriptor ; , efavirenz Sustiva ; , nevirapine Viramune ; . Other- hydroxyurea Hydrea ; . OI DRUGS PHS "A1 OI"s- acyclovir Xovirax ; , azithromycin Zithromax ; , cidofovir Vistide ; , clarithromycin Biaxin ; , famciclovir Famvir ; , fluconazole Diflucan ; , foscarnet Foscavir ; , ganciclovir Cytovene ; , isoniazid generic ; , itraconazole Sporonox ; , leucovorin calcium Wellcovorin ; , pyrimethamine Daraprim ; , sulfadiazine oral generic ; , TMP SMX Bactrim, Septra ; . Other OIs- albendazole Albenza ; , amikacin sulphate generic injection ; , amoxicillin trihydrate oral generic ; , amphotericin B Fungizone ; , atovaquone Mepron ; , bleomycin sulfate Blenoxane ; , ciprofloxacin Cipro ; , clindamycin Cleocin ; , clofazimine Lamprene ; , clotrimazole Lotrimin, Mycelex ; , cyclophosphamide Cytoxan ; , dapsone Avlosulfon ; , dexamethasone Decadron ; , doxorubicin Adriamycin ; , epoetin alpha Procrit ; , ethambutol Myambutol ; , filgrastim Neupogen ; , flucytosine 5FC, Ancobon ; , fomivirsen Vitravene ; , ketoconazole Nizoral ; , isoniazid rifampin generic ; , liposomal duanorubicin DaunoXome ; , methotrexate oral, injection ; , metronidazole oral generic ; , nystatin Mycostatin ; , paclitaxel Taxol ; , paromomycin Humatin ; , pentamidine Nebupent, Pentam ; , prednisone oral generic ; , pyrazinamide generic ; , rifabutin Mycobutin ; , rifampim generic ; , trimethoprim Trimpex, Proloprim ; , trimetrexate glucuronate NeuTrexin ; , valganciclovir Valcyte ; , valacyclovir Valtrex ; , vinblastine sulfate Velban ; , vincristine sulfate Oncovin ; . Hepatitis C- interferon alfacon 1 Infergen ; , interferon A-2A Intron-A, Roferon-A ; , ribavirin generic ; , ribavirin interferon alpha 2B Rebetron ; . TREATMENTS FOR METABOLIC DISORDERS Diabetic- glipizide Glucotrol ; , rosiglitazone maleate Avandia ; . Hyperlipidemia- atorvastatin Lipitor ; , gemfibrozil generic only ; , pravastatin Pravachol ; , simvastatin Zocor ; . Wasting- dronabinol Marinol ; , megestrol acetate Megace ; , nandrolone Durabolin, Deca-Duranbolin ; , oxandrolone Oxandrin ; , somatropin Serostim ; , testosterone generic injection, transdermal ; . ALL OTHERS alitretinoin gel Panretin Gel ; , alprazolam Xanax ; , amitriptyline hydrochloride generic ; , bupropion HCL Wellbutrin ; , buspiron HCL BuSpar ; , cephalexin oral generic ; , citalopram hydrobromide Celexa ; , codeine w wo ASA, APAP oral generic ; , desipramine HCL oral generic ; , dicloxacillin sodium oral generic ; , diphenoxylate HCL Lomotil ; , divalproex sodium Depakote ; , doxycycline hyclate oral generic ; , erythromycin oral generic ; , famotidine generic ; , fenoprofen calcium oral generic ; , fentanyl Duragesic, hospice clients only ; , fluoxetine HCL Prozac ; , gabapentin Neurontin ; , hepatitis A vaccine, hepatitis B vaccine, hydrocodone w wo APAP oral generic ; , ibuprofen-prescription strength generic ; , imiquimod Aldara ; , indomethacin oral generic ; , ketoprofen oral generic ; , ketorolac tromethamine Toradol injection ; , lamotrigine Lamictal ; , lansoprazole Prevacid ; , levorphenol tartrate Levo-Dromoran ; , loperamide HCL generic ; , lorazepam oral generic ; , methadone HCL oral generic ; , metoclopramide Reglan, Clopra ; , minocycline HCL oral generic ; , morphine sulfate oral generic ; , naproxen oral generic ; , nefazodone HCL Serzone ; , neomycin sulfate oral generic ; , nortriptyline HCL oral generic ; , olanzapine Zyprexa ; , omeprazole Prilosec ; , opium, tincture of, oxycodone w wo ASA, APAP oral generic ; , pancrelipase Ultrase ; , paroxetine HCL Paxil ; , penicillin V potassium oral generic ; , pneumococcal vaccine Pneumovax, Pnu-Immune ; , probenecid generic ; , prochlorperazine Compazine ; , promethazine Phenergan ; , quetiapine fumarate Seroquel ; , ranitidine HCL prescription strength generic ; , risperidone Risperdal ; , sertraline Zoloft ; , sulindac oral generic ; , tetracycline HCL oral generic ; , trazodone HCL oral generic ; , vancomycin HCL oral generic ; , venlafaxine HCL Effexor and flagyl. Zovirax indications and dosageAll general dental practitioners and dental care professionals are required to be able to manage medical emergencies, which includes the administration of drugs. A list of drugs for use in medical emergencies is included in Section 2, together with information about their administration. This list reflects the emergency drugs recommended in BNF 551 and in Resuscitation Council UK ; guidance3, and supersedes the list of emergency drugs included in NDAC guidance4 published in 1999. In addition, brief details of the signs and symptoms of medical emergencies that might occur in primary care dental practice are provided. Information regarding administration of drugs used in medical emergencies is provided in white boxes on the left, with any differences in the doses or formulations for children provided in blue boxes on the right. This advice is based on information provided in BNF 551 and BNFC 20072, and guidance published by the Resuscitation Council UK ; 3. Refer to guidance from the Resuscitation Council UK ; 3 resus pages MEdental ; for more-detailed advice on how to recognise, assess and manage medical emergencies and for details of the equipment and training required to be able to deal with medical emergencies and resuscitation effectively and bactrim. NDA 20-487 S-007 Page 9 Valacyclovir was mutagenic in a mouse micronucleus assay. Valacyclovir did not impair fertility or reproduction in rats at 6 times human plasma levels. Pregnancy: Teratogenic Effects: Pregnancy Category B. Valacyclovir was not teratogenic in rats or rabbits at 10 and 7 times human plasma levels, respectively, during the period of major organogenesis. There are no adequate and well-controlled studies of VALTREX or ZOVIRAX in pregnant women. A prospective epidemiologic registry of acyclovir use during pregnancy was established in 1984 and completed in April 1999. There were 749 pregnancies followed in women exposed to systemic acyclovir during the first trimester of pregnancy resulting in 756 outcomes. The occurrence rate of birth defects approximates that found in the general population. However, the small size of the registry is insufficient to evaluate the risk for less common defects or to permit reliable or definitive conclusions regarding the safety of acyclovir in pregnant women and their developing fetuses. VALTREX should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Nursing Mothers: Following oral administration of a 500-mg dose of VALTREX to 5 nursing mothers, peak acyclovir concentrations Cmax ; in breast milk ranged from 0.5 to 2.3 times median 1.4 ; the corresponding maternal acyclovir serum concentrations. The acyclovir breast milk AUC ranged from 1.4 to 2.6 times median 2.2 ; maternal serum AUC. A 500-mg maternal dosage of VALTREX twice daily would provide a nursing infant with an oral acyclovir dosage of approximately 0.6 mg kg day. This would result in less than 2% of the exposure obtained after administration of a standard neonatal dose of 30 mg kg day of intravenous acyclovir to the nursing infant. Unchanged valacyclovir was not detected in maternal serum, breast milk, or infant urine. VALTREX should be administered to a nursing mother with caution and only when indicated. Pediatric Use: Safety and effectiveness of VALTREX in pre-pubertal pediatric patients have not been established. Geriatric Use: Of the total number of subjects in clinical studies of VALTREX, 906 were 65 and over, and 352 were 75 and over. In a clinical study of herpes zoster, the duration of pain after healing post-herpetic neuralgia ; was longer in patients 65 and older compared with younger adults. Elderly patients are more likely to have reduced renal function and require dose reduction. Elderly patients are also more likely to have renal or CNS adverse events. With respect to CNS adverse events observed during clinical practice, agitation, hallucinations, confusion, delirium, and encephalopathy were reported more frequently in elderly patients see CLINICAL PHARMACOLOGY, ADVERSE REACTIONS: Observed During Clinical Practice, and DOSAGE AND ADMINISTRATION ; . ADVERSE REACTIONS Frequently reported adverse events in clinical trials of VALTREX in healthy patients are listed in Tables 4 and 5. Table 4. Incidence % ; of Adverse Events in Herpes Zoster Study Populations VALTREX 1 gram t.i.d. Placebo n 195 ; Adverse Event n 967 ; Nausea 15% 8% Headache 14% 12% Vomiting 6% 3% Dizziness 3% 2% Abdominal pain 3% 2. Herpes simplex virus type 1 HSV-1 ; reactivation has serious local implications due to pain, impaired hydration and nutrition. It most commonly occurs in conjunction with chemotherapy mucositis, resulting in multiple ulcerations involving any intraoral and perioral soft tissue surfaces. Since these patients are expected to develop mucositis secondary to their chemotherapy, HSV reactivation may be overlooked as an etiologic component. Mucositis complicated by HSV reactivation tends to be more severe and last longer. In leukemia and bone marrow transplantation patients, reactivation of HSV occurs in 50-80% of HSV seropositive patients. Prophylactic acyclovir offers effective control and is commonly used in bone marrow transplant patients. However, it is not routinely used in patients on cancer chemotherapy. These patients should be evaluated closely for HSV reactivation. The systemic consequence of HSV infection is the disruption of the mucosal barrier, allowing a portal of entry for commensal oral microorganisms, which can lead to sepsis. Herpes varicella zoster virus VZV ; cytomegalovirus CMV ; , Epstein-Barr virus EBV ; , human herpesviruses HHV-6, 7, 8 ; as well as community respiratory viruses, although much less common than HSV, have also proven problematic during the course of chemotherapy. Procedures to manage viral infections are summarized below: O O O All mucositis lesions in HSV antibody positive patients should be cultured for HSV unless the patient is already taking or has been prophylaxed with acyclovir Zoviarx ; . Ointments containing acyclovir antivirals are probably not appropriate for these patients as extent of disease requires systemic therapy. Outpatient treatment for less severe disease: acyclovir capsules Inpatient treatment in patients with severe disease: acyclovir IV Other options with advantage of better patient compliance but higher cost: G Famcyclovir Famvir ; G Valacyclovir Valtrex ; For acyclovir-resistant viruses, other antiviral agents include: G Foscarnet Foscavir ; G Brivudin G Brovavir Cytomegalovirus CMV ; infection is not uncommon in immunosuppressed transplant ; patients. Systemic antiviral gancyclovir ; is the treatment of choice and cefadroxil. Up to 2 hours after administration of PL. Histologically, PL treated biopsy specimens showed less sunburn cells P .05 ; , cyclobutane pyrimidine dimers P .001 ; , proliferating epidermal cells P .001 ; , and dermal mast cell infiltration P .05 ; . A trend toward Langerhans cell preservation was seen. Conclusion : Oral administration of PL is effective systemic chemophotoprotective agent leading to significant protection of skin against UV radiation. Mouth three times a day or valacyclovir Valtrex ; 1.0 gram by mouth twice a day, all given seven to ten days. Valtrex is frequently held as a backup in initial cases that do not respond well to oral Zovirax or Famvir, as is intravenous Zovirax. Treating early shortens the duration of symptoms, reduces viral shedding and reduces the systemic symptoms, but does not influence the probability of recurrence. For severe infections or those not responding to first-line therapy, the dose of acyclovir may be increased up to 800 mg by mouth five times a day or intravenously 1530 mg per kilogram of body weight per day, either for at least seven days. Valacyclovir may be an alternative in these cases, as may foscarnet. For recurrent infections, the same dose is often effective in a somewhat shorter course five days ; , with early initiation of treatment very strongly recommended. Prophylaxis may be indicated for individuals prone to frequent or severe infections, and is usually done by giving acyclovir 400 mg by mouth twice a day, famciclovir 125250 mg by mouth twice a day or valacyclovir 500 mg by mouth twice a day or 1 gm once a day. Of course, the tradeoff danger of giving prophylaxis is possibly speeding the emergence of drug resistance, so some clinicians prefer to reserve the drugs for rapid initiation of treatment of each recurrence. Note: These recommendations may be verified and more information gained by consulting the Johns Hopkins University AIDS Service web site at : hopkinsaids publications book ch5 viruses and ceftin.
Since doctors rely on your description of pain to help guide treatment, you may want to keep a pain diary to record your pain sensations. You can begin a week or two before your visit to the doctor. On a daily basis, you can describe the situations that cause or alter the intensity of your pain, the sensations and severity of your pain, and your reactions to the pain. For example: "On Monday night, sharp pains in my knees produced by housework interfered with my sleep; on Tuesday morning, because of the pain, I had a hard time getting out bed. However, I coped with the pain by applying ice to my knees." The diary will give the doctor some insight into your pain and may play a critical role in the management of your disease. But there is much doctors do not know about handling arthritis so it is always good to be informed for yourself.
Your doctor has weighed the expected benefits against possible risks of you using zovirax eye ointment and amoxil. Zovirax ointment 5Zovirax side effects medicationZivirax, zobirax, zovirsx, zovlrax, zovi5ax, zovirxa, zovieax, zovirad, zoviraxx, zovvirax, zov8rax, zogirax, zovurax, ozvirax, zovirzx, xovirax, zovkrax, aovirax, zovriax, ovirax, zovifax, zoviirax, zoviraz, zoviras, zovidax, zofirax, zoivrax, zovorax.Cheap zoviraxZovirax indications and dosage, zovirax ointment 5, zovirax side effects medication, cheap zovirax and can kids use zovirax. Buy zovirax ointment without a prescription, zovirax children, zovirax next day and zovirax iv package insert or discount zovirax. Can kids use zoviraxHow plants absorb nutrients, aseptic necrosis joint, vitreous implant, short bowel syndrome and nutrition and tachycardia low potassium. Alprazolam 1 2, germanium on insulator, anterograde neurotrophin mechanism and vitamin b6 diuretic or cancer care of oklahoma. © 2009 |